Research & development > Clinical diagnostics

AI-based liquid biopsy could detect ovarian cancer earlier

03 October, 2024

A blood test that uses a combination of artificial intelligence (AI) and protein biomarkers could help screen women for early signs of ovarian cancer.


'Casual' gestational diabetes test misses 70% of cases

19 September, 2024

When screening pregnant women for gestational diabetes, casual blood glucose testing misses 70% of cases.


Blood test shows promise for early diagnosis of Alzheimer's

12 September, 2024

The test assesses the relative levels of potassium isotopes in human blood serum and shows potential to diagnose Alzheimer's before cognitive decline becomes apparent.


Saliva test enables heart failure screening at home

30 August, 2024

The point-of-care electrochemical biosensor prototype can measure levels of two biomarkers for heart failure in as little as 15 min from just a drop of saliva.


Blood test predicts chronic lung disease in preterm babies

14 August, 2024

Changes in certain blood proteins, alongside gestational age, birth weight and sex, strongly predict bronchopulmonary dysplasia (BPD) within 72 hours of life.


Nanotech device enables early lung cancer detection

07 August, 2024

A drop of blood could be all that's needed to alert clinicians to the presence of small lung cancer nodules and allow intervention while the disease is in its early stages.


Urine test detects cervical cancer virus proteins

17 July, 2024

Scientists have found a way to detect HPV oncoproteins in urine, which could encourage more women to participate in regular cervical cancer screening.


Blood test can track the brain's recovery after concussion

20 June, 2024

A blood test can accurately detect the ongoing effects of sport-related concussion and help determine when it's safe to return to the field, according to an international study.


Two new methods for faster sepsis diagnosis

12 April, 2024

Sepsis and septic shock patients could soon experience faster diagnoses and better outcomes, thanks to new Australian research.


Biomarker could prevent sudden cardiac death in men

12 March, 2024

Plasma 4β-hydroxycholesterol (4βHC) measurement could help to predict and prevent sudden cardiac death in men with coronary artery disease, according to researchers.


Blood test can predict risk of imminent heart attack

04 March, 2024

A new online tool lets users input their blood test results along with other basic information to discover if they are at increased risk of having a heart attack within six months.


Boldly going in search of the fabled tricorder

19 February, 2024 by Ivor Campbell*

Diagnostics companies globally continue to beaver away in search of a machine capable of diagnosing the highest number of possible conditions within a single technology.


Glowing COVID test produces results in 1 min

23 January, 2024

What if, instead of taking 15 minutes or more, a COVID-19 test could quite literally light up with a result in just one minute?


An AI-assisted diagnostic test for COVID and other diseases

12 January, 2024

The AI model has been trained to read the results of tests identifying infectious diseases, including COVID-19, and removes user error while improving accuracy.


New tumour marker identifies early-stage gastric cancer

05 December, 2023

The new tumour marker has a sensitivity of 89% and a specificity of 99%, far exceeding the sensitivity of conventional tumour markers in identifying cancer patients.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd